Argent BioPharma Limited
RGTLF
$0.0599
$0.011423.51%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -71.84% | -75.86% | -3.74% | -1.18% | 35.56% |
| Total Depreciation and Amortization | -- | -- | -16.13% | -18.25% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 976.17% | 996.61% | 132.22% | 126.50% | -119.90% |
| Change in Net Operating Assets | -- | -- | -166.09% | -164.47% | -- |
| Cash from Operations | 45.93% | 44.67% | -27.41% | -24.27% | -15.99% |
| Capital Expenditure | 87.27% | 85.45% | -363.64% | -357.96% | 92.91% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 87.27% | 85.45% | -267.77% | -263.97% | -103.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -12.09% | -12.09% | -44.36% | -44.36% | -1.17% |
| Issuance of Common Stock | -68.92% | -68.92% | -65.46% | -65.46% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 68.21% | 68.21% | 149.78% | 149.78% | -- |
| Cash from Financing | -69.64% | -68.93% | -74.47% | -75.10% | 157.18% |
| Foreign Exchange rate Adjustments | -235.29% | -235.29% | 50.00% | 51.28% | -54.05% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -99.75% | -99.75% | -537.96% | -522.06% | 921.86% |